GROZA Tudor

Adj A/Prof Tudor Groza is the co-lead of AI and Data Science at the Maternal and Child Health Research Institute, KK Women’s and Children’s Hospital, Singapore, Principal Scientist at the Bioinformatics Institute, A*STAR, and Deputy CTO (Health System Integration) of the National Precision Medicine Program Singapore. His work spans various dimensions of the research – clinical care continuum, from devising algorithms to support clinical decision-making, to standardization of clinical terminology and integration with national public and private health systems.

Over the course of the last 15 years, Tudor focused on contributing to the clinical phenotyping community by building deep phenotyping tools to aid the decision-making process in clinical genomics and primary care. He led several global phenotype standardization initiatives, including the Phenotype Representation group and the Rare Disease Community of Interest in the Global Alliance for Genomics and Health (GA4GH), or the Data Sharing group within the Undiagnosed Diseases Network International.

As an entrepreneur, he was the CTO of Genome.One, where he led the Personal Health Applications business unit through a clinical accreditation. In 2018, he co-founded Pryzm Health with the goal of reducing the diagnostic odyssey for patients susceptible to rare disorders by introducing phenotype-driven patient stratification methods in primary care. Before joining MCHRI and A*STAR, he led the Phenomics team at the European Bioinformatics Institute, where he contributed to the acceleration of translational and clinical applications of genomic technologies by creating comprehensive disease models using cross-species phenotype data, and was part of the Rare Care team at the Perth Children’s Hospital, where we focused on using phenotype trajectories to build care coordination pathways for patients with rare disorders.